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Abstract
Glomerular diseases account for the majority of cases with chronic renal failure. Several genes have been identified with key
relevance for glomerular function. Quite a few of these genes show a specific or preferential mRNA expression in the renal
glomerulus. To identify additional candidate genes involved in glomerular function in humans we generated a human renal
glomerulus-enriched gene expression dataset (REGGED) by comparing gene expression profiles from human glomeruli and
tubulointerstitium obtained from six transplant living donors using Affymetrix HG-U133A arrays. This analysis resulted in 677
genes with prominent overrepresentation in the glomerulus. Genes with ‘a priori’ known prominent glomerular expression
served for validation and were all found in the novel dataset (e.g. CDKN1, DAG1, DDN, EHD3, MYH9, NES, NPHS1, NPHS2, PDPN,
PLA2R1, PLCE1, PODXL, PTPRO, SYNPO, TCF21, TJP1, WT1). The mRNA expression of several novel glomerulus-enriched genes in
REGGED was validated by qRT-PCR. Gene ontology and pathway analysis identified biological processes previously not reported
to be of relevance in glomeruli of healthy human adult kidneys including among others axon guidance. This finding was further
validated by assessing the expression of the axon guidancemolecules neuritin (NRN1) and roundabout receptor ROBO1 and -2. In
diabetic nephropathy, a prevalent glomerulopathy, differential regulation of glomerular ROBO2 mRNAwas found. In summary,
novel transcripts with predominant expression in the human glomerulus could be identified using a comparative strategy on
microdissected nephrons. A systematic analysis of this glomerulus-specifc gene expression dataset allows the detection of target
molecules and biological processes involved in glomerular biology and renal disease.
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Introduction
The majority of renal diseases leading to end-stage renal
diseases (ESRD) are initiated by glomerular alterations [1].
Hereditary, immune-mediated and metabolic disorders can cause
such glomerulopathies, but the understanding of the pathome-
chanism of the most common glomerular diseases is still limited.
The renal glomerulus is capable of filtering large volumes of
plasma while efficiently retaining most proteins within the
circulation [2]. The development and maintenance of normal
glomerular structure and function requires successful signaling and
coordination between all glomerular cells, as shown by the critical
requirement for vascular endothelial growth factor-A (VEGFA)
production by podocytes for normal endothelial and mesangial cell
development and function [3,4].
Podocytes are a unique cell type in the glomerulus [5]. Several
genetic studies clearly demonstrated that mutations of proteins,
which are preferentially or specifically expressed in this cell type,
can cause renal disease leading to the disruption of the filtration
barrier, rearrangement of the actin cytoskeleton and ultimately
glomerular failure (e. g. a-actinin-4, nephrin, podocin) [6].
Additional studies revealed that proteins regulating the plasticity
of the podocyte actin cytoskeleton, such as podocalyxin [7], FAT1
[8], Nck1 and Nck2 [9], synaptopodin [10] and Cathepsin L [11],
are also crucial for the function of the glomerular filtration barrier.
But also signaling mechanisms in the podocyte including signals
from the slit diaphragm (SD) or from the glomerular basal
membrane (GBM) are important (e.g. PLCE1, TRPC6, PTPRO,
ILK, uPAR [12,13,14]). Transcriptional regulation of genes
expressed in the glomerulus plays a key role for functional
integrity. Transcription factors that have been associated with
glomerular disorders include WT1, FOXC2, LMX1B, TCF21,
PAX2 and others [15]. Furthermore the composition and charge
of the GBM (e.g. LAMB2, COL4A3, 24, 25), the endothelial
cells with their unique fenestration (e.g. EHD3) [6] and the
mesangial cells play a crucial role. Studies could outline important
species-dependent differences in glomerular gene expression, e.g.
megalin was shown to be the target autoantigen in experimental
Heyman nephritis is absent from the human glomerulus, whereas
PLA2R seems to be a target autoantigen in human idiopathic
membranous nephropathy [16]. As the glomerular transcriptome
of rodents and humans show significant differences, a reliable and
comprehensive human data set is required.
Identification of additional human glomerular-enriched genes
and proteins as well as molecular mechanisms and gene networks
represent a promising approach to the understanding of
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development and function of the glomerulus and its derangement
in glomerular diseases.
In the present study, gene expression profiles from human
glomeruli and tubulointerstitium obtained from transplant living
donors were compared to each other in order to generate a human
renal glomerulus-enriched gene expression dataset (REGGED).
REGGED aims to facilitate the identification of gene products and
mechanisms important in regulation of renal glomerular structure
and function. The mRNA expression for several novel glomerular-
enriched genes was verified by qRT-PCR. Gene ontology analysis
by Database for Annotation, Visualization and Integrated
Discovery (DAVID), as well as the Kyoto Encyclopedia of Genes
and Genomes (KEGG) database identified pathways and gene
categories well-known to be associated with glomerular biology but
additionally pathways not previously reported to be involved in
glomeruli of healthy human adult kidneys. Axon guidance,
identified by this means as a biological process in human mature
glomeruli, was used to validate our approach and the expression of
the axon guidance molecules neuritin (NRN1) and roundabout
receptor ROBO1 and -2.
In summary, REGGED represents a resource for the glomer-
ular research community to interrogate genes identified by in vitro
systems, rodent models, or human genetic screens for their
enrichment in the glomerular compartment. It further will help to
prioritize biological processes in functional studies on glomerular
biology.
Results
Generation of a human renal glomerulus-enriched gene
expression dataset (REGGED) and comparison with
published data sets
To identify genes restricted to or enriched in the glomerulus,
we compared gene expression profiles of isolated human
glomeruli with the tubulointerstitial compartment from biopsies
of living donors using Affymetrix HG-U133A arrays. By
application of the algorithms given in the Methods section a
total of 817 probesets were identified as being glomerular-
enriched. After removing unannotated probesets and redundant
probesets a list of 677 glomerular-overrepresented genes
remained (Supplementary Table S1). For validation of the
dataset an arbitrary list of known genes with specific or
pronounced expression in the renal glomerulus of different
species was generated and compared with REGGED (Supple-
mentary Table S2). Known prominent glomerular transcripts
such as CDKN1, DAG1, DDN, EHD3, MYH9, NES, NPHS1,
NPHS2, PDPN, PLA2R1, PLCE1, PODXL, PTPRO, SYNPO,
TCF21, TJP1, WT1 were all found in the novel expression
dataset REGGED (Figure 1) [15,17,18,19,20,21,22,23,24,25]. In
a next step, a comparative analysis of different expression
platforms was performed. To this end we focused on human
data sets and used data published by Chabardes-Garonne et al
[26], Higgins et al. [27], Cuellar et al [28], and Nystro¨m et al.
[29]. The two SAGE profiling analyses by Chabardes-Garonne
and Nystro¨m identified 153 [26] and 492 genes [29], respectively,
as being predominantly expressed in the glomerulus compared
with other parts of the nephron. The Stanford cDNA microarray
profiling by Higgins et al. resulted in 102 [27] glomerular
markers, while the plasmid library by Cuellar identified 205 [28]
glomerular-enriched genes. Table 1 summarizes the characteris-
tics of the 5 analyses including the present study. The comparison
of the 5 different approaches is illustrated in Figure 1 and
Supplementary Table S3. REGGED contains a number of genes
with established function in glomerular biology, which were not
previously found in human data sets (e.g. FYN, MYH9, PDPN)
[13,20,30,31]. Similar to He et al [32], who compared rodent
and human data sets, only 6 genes were identified in all studies,
namely the podocyte-expressed genes CDKN1C, PTPRO,
SPARC, and PLAT, the endothelial marker EMCN, and the
mesangial-expressed IGFBP5.
Gene Ontology and Pathway Analysis
As gene lists per se need to be integrated in a functional context,
we mapped the REGGED genes into different biological
categories according to gene ontology (GO). A relative ranking
of the association of the various GO-categories with respect to the
gene list was carried out employing DAVID, a web-based tool
developed for GO-ranking. Although GO enrichment analysis has
some limitations [33], it is an efficient means to extract the
biological meaning behind large gene list. DAVID analysis of all
677 glomerular-enriched genes yielded 197 GO-categories
(Supplementary Table S4; cut-off p-value 0.05, Fold enrichment
.1.5). To receive a more comprehensive and structured view of
the annotation terms a DAVID clustering analysis under high
stringency conditions was performed resulting in ten annotation
clusters matching the statistical criteria [(p,0.05), fold enrichment
.1.5 and an enrichment score of at least 2.0]. Each of these
clusters was composed of at least 3 annotation terms, with an
enrichment score of 2.01–7.34 (Supplementary Table S5 and
Supplementary Figure S1). As an example functional cluster 2 is
shown in more detail in Figure 2; it is composed of ten GO terms
that apply to identical sets of genes.
Subsequently, the aforementioned DAVID annotation tool was
used for identification of putative KEGG pathways associated with
glomerular biology. The glomerular-enriched genes could be
mapped to 105 pathways, 12 of which were significantly enriched
with glomerular-associated genes (p,0.05, Fold enrichment .1.5)
(Supplementary Table S6). For instance, we found the KEGG
terms ‘‘regulation of actin cytoskeleton’’, ‘‘focal adhesion’’ and
‘‘tight junction’’ to be significantly enriched pathways, which are
known to be of relevance for glomerular biology. Interestingly,
‘‘axon guidance’’, one of the GO terms associated with
glomerular-enriched genes, was also pinpointed in the KEGG
pathway analysis.
Comparison with neuronal related genes and genes
mainly expressed in smooth muscle cells as well as in
muscle and heart
Several studies have shown that glomerular podocytes and
neurons share some specific characteristics. For instance, both cells
are highly arborized, have a common cytoskeletal organization
and signaling processes, and share several expression-restricted
proteins, such as NPHS1, LRRC7, PTPRO, KHDRBS3, or
SYNPO [34,35]. We therefore conducted a digital differential
display analysis to compare normal adult brain cDNA libraries
(total of 27,891 sequences) with other tissue libraries except for
testis (143,877 sequences). Testis libraries were excluded because
of the significant similarity of its transcriptome to the one of brain
[36]. DDD takes advantage of the UniGene database by
comparing the number of times that sequences from different
libraries are assigned to a particular UniGene cluster. This analysis
produced 186 UniGene clusters that were potentially specific to
the brain pool. Combining this list of UniGene clusters with a
literature-derived list of neuronal related molecules [37], we
generated a list of 414 neuronal/brain-associated genes (Supple-
mentary Table S7) and compared it with REGGED. This
comparison revealed that 38 of the 414 neuron/brain-associated
Glomerular Gene Expression
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genes were present in the glomerular dataset (Supplementary
Table S8).
More and more studies have demonstrated that myosin or
smooth muscle-related molecules participate in glomerular biology
and development of renal disease [20,30,38,39]. We therefore
conducted two further DDD analyses comparing a coronary artery
smooth muscle cell cDNA library (total of 7,220 sequences) or
normal adult muscle and heart cDNA libraries (total of 12,861
sequences) with other tissue libraries (176,036 and 163,171
sequences, respectively). These analyses resulted in 90 and 161
UniGene clusters, respectively, which were potentially enriched in
smooth muscle cells or muscle and heart. Comparison of the
Figure 1. Venn diagram for five human glomerular data set reports. Established glomerular genes are shown in squares. REGGED is the only
data set covering all such preselected glomerular gene products. The overlap among the five glomerulus-enriched gene lists is limited (see Table 1).
doi:10.1371/journal.pone.0011545.g001
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smooth muscle cell dataset with REGGED revealed an overlap of
9 genes (Supplementary Table S9). For the comparison of the
muscle and heart dataset with REGGED an overlap of 17 genes
was found (Supplementary table S10) including genes previously
reported to be expressed in the glomerulus such as GSN, NEBL or
TNNC1 [40,41]. As expected, MYH9, for which genetic variants
were found to be associated with non-diabetic end-stage renal
disease [20,30], is missing in these lists as it encodes a non-muscle
myosin chain.
Validation by real-time RT-PCR
DDD as well as GO and KEGG analyses revealed axon
guidance-related genes to be overrepresented in the renal
glomerulus. We decided to focus on 4 selected neuronal associated
genes in closer detail: neural proliferation differentiation and
control 1 (NPDC1), neuritin (NRN1), roundabout receptor 1 and
2 (ROBO1, ROBO2, the latter not on the HG-U133A array and
therefore not in REGGED, but found in rodent glomeruli by
[42]). For initial further validation real-time RT-PCR was
performed on an independent cohort of microdissected samples
of allograft donors. Figure 3 displays the results for NPDC1,
NRN1, ROBO1 and ROBO2 mRNA expression. The abundance
of all these genes was significantly higher in glomeruli than in the
tubulointerstitium ranging from approximately 9-fold (NPDC1) to
130-fold (ROBO2).
Protein expression of neuritin (nrn1) and robo1 in
cultured podocytes and in healthy human control
kidneys
The protein expression of neuritin and roundabout receptor 1,
both known to be involved in axon guidance and neurite
outgrowth, was assessed by Western blot in podocytes. Both
proteins, robo1 and neuritin, were found to be expressed on
protein level in a human podocyte cell line; human brain lysate
served as a positive control (Figure 4A and B).
Immunofluorescence experiments were performed to analyze
the cellular localization of robo1 and neuritin in podocytes
(Figure 5) as both proteins were well expressed on mRNA level in
these cell types. In undifferentiated immortalized podocytes
(33uC), a cytoskeletal staining for robo1 was found, while in
differentiated cells (37uC) a more intense staining of the cell border
was observed (Figure 5A). For neuritin a cytoskeletal staining
pattern could be observed in undifferentiated and differentiated
cells, in the latter a more pronounced staining of stress fibers was
seen (Figure 5B).
To evaluate the protein expression of both axon guidance
molecules in vivo, immunofluorescence staining for robo1 and
neuritin was performed on an independent set of healthy control
kidneys. For robo1 expression in the glomerulus could be detected,
while the staining was either completely absent or showed a
minimal scattered positivity in the tubulointerstitial compartment.
Neuritin showed a clear staining of the glomerulus, but also some
positive signal in the tubulointerstitium (Figure 6A and B). This is
consistent with REGGED and the qRT-PCR experiments
indicating an enhanced but not specific glomerular expression of
neuritin in the human adult healthy kidney.
Regulation of mRNA for the axon guidance molecules
NRN1, ROBO1 and ROBO2 in different renal diseases
To investigate intrarenal disease associated regulation of NRN1,
ROBO1 and ROBO2 mRNA, we assessed the renal expression on
microdissected glomeruli of cohorts with diabetic nephropathy
(DN), nephrosclerosis (NSC), focal-segmental glomerulosclerosis
(FSGS), membranous glomerulonephropathy (MGN) and pre-
transplant biopsies. Compared to normal glomeruli obtained from
living donors we found a significantly lower expression of ROBO2
mRNA in DN and a trend towards a decreased expression in
FSGS patients. ROBO1 and NRN1 mRNA showed no significant
change in the disease cohorts (Figure 7).
Discussion
We compared microarray gene expression data from human
glomeruli and tubulointerstitium obtained from transplant living
donors to generate a human renal glomerulus-enriched gene
expression dataset which contained 677 glomerulus-enriched
or -restricted genes.
Comparison of our study with earlier reports of human
glomerular-enriched databases using different techniques resulted in
a limited overlap (Figure 1). This is in accordance with a meta-
analysis performed by He et al [32] comparing different platforms
and species. These results suggest that the differences may result from
the different technical platforms, glomerular isolation protocols,
normalization and processing of the raw data as well as different
categorization criteria. In our study we used the Affymetrix platform
which identified the highest number of glomerulus-enriched genes
compared to the other techniques, again in accordance with the
Table 1. Summary of the characteristics of the five methods.
Investigator Method Species
Total Features
on the platform
Glomerulus-
enriched genes
reported Selection criteria Reference
Chabardes-Garonne et al SAGE profiling Human 50 000 tags 153 P,0.01, seven-fold or more difference
with at least three nephron libraries
[26]
Higgins et al Stanford cDNA
microarray profiling
Human 41.859 probes 102 Cluster analysis, genes predominantly
expressed in glomeruli than others
[27]
Cuellar et al cDNA library (Plasmid
cloning)
Human 5000 clones 205 Sequence analysis and comparison with
UniGene database
[28]
Nystrom et al SAGE profiling Human 22907 tags 492 Comparison to pooled SAGE libraries for
non-glomerular tissues and cells
[29]
Lindenmeyer et al Affymetrix HG-U133A Human 22283 probesets 677 Comparison of isolated glomeruli with
tubulointerstitial compartment from
biopsies of living donors
doi:10.1371/journal.pone.0011545.t001
Glomerular Gene Expression
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report of He et al. [32]. REGGED was in comparison to the other
human databases clearly enriched for known podocyte- and
glomerulus-enriched genes as summarized in Figure 1. Furthermore
REGGED contained some genes, such as PDPN, FYN or MYH9,
which are known to be of relevance for glomerular biology, but were
missing in the other human databases.
Figure 2. DAVID Functional Cluster Analysis – genes involved in functional cluster 2. Genes which are involved in the respective biological
GO-term are shown in black.
doi:10.1371/journal.pone.0011545.g002
Glomerular Gene Expression
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To gain further information about the biology represented by this
gene set we performed GO and pathway analysis using DAVID and
the KEGG database. FromGO-analysis, cytoskeleton-associated GO
categories were identified as being significantly enriched in the
glomerular dataset, which was further confirmed by the KEGG-
pathways ‘‘regulation of actin cytoskeleton’’, ‘‘focal adhesion’’, and
‘‘tight junction’’. This is in accordance with several reports indicating
that the function of podocytes, one of the three intrinsic glomerular
cell types, is dependent on the plasticity of its unique and complex
cytoskeletal architecture [43] and that podocyte injury with
disruption of their specialized functions leads to proteinuria and foot
process effacement.
One characteristic of podocytes is that except in collapsing
FSGS the differentiated podocytes do not proliferate. Once
podocytes are mature and terminally differentiated they remain
in a quiescent state and express cyclin-dependent kinase inhibitors
p27 and p57, which are present in REGGED, and do not express
markers of proliferation (cyclin A, cyclin D, and Ki-67) [44]. This
feature of cell cycle arrest may be the cause why the GO-analysis
of the current glomerular dataset revealed several GO categories
associated with cell cycle, cell growth and cell death.
Several studies have shown that podocytes share some
similarities with neuronal cells. Both cells possess a highly
arborized morphology, share many common cytoskeletal proteins
such as synaptopodin, drebrin and densin resulting in a common
cytoskeletal organization, have a common machinery for process
formation [45] and express proteins primarily or exclusively found
in neurons and podocytes, e.g. nephrin [46], glomerular epithelial
protein 1 (GLEPP1) [47], synaptic vesicle molecule Rab3A and its
effector rabphilin-3A [37], the RNA processing protein Sam68-
like mammalian protein 2 (SLM2) [34] and the ubiquitin C-
terminal hydrolase-L1 (UCH-L1) [48]. DDD analysis showed an
enrichment of neuronal associated genes, and gene ontology as
well as pathway analysis confirmed an association between
neurons and glomeruli by identifying processes such as ‘‘neuro-
genesis’’ and ‘‘axon guidance’’ as being significantly overrepre-
sented in this glomerular dataset. We selected 4 neuronal genes,
which are associated with axon guidance (NRN1, ROBO1,
ROBO2) or the control of proliferation and differentiation of
neural cells (NPDC1). qRT-PCR analysis on human biopsies
confirmed the overrepresentation of these genes in the glomerulus.
Of interest, a human glomerular enrichment was only recently
reported for NRN1 and NPDC1 [29] but not for ROBO1 and -2.
As ‘‘axon guidance’’ was one of the processes shown to be
significantly overrepresented in REGGED, we focused in the
further course of the study on genes involved in axon guidance, a
process that has not been previously described in the glomerulus of
healthy human adult kidneys. Neuritin (NRN1) is a glycosylpho-
sphatidylinositol-anchored protein that is induced by neuronal
activity and by the neurotrophins BDNF and NT-3. It promotes
neurite outgrowth and arborization as well as neuronal survival
[49,50]. In this study we found neuritin to be enriched in the
glomerulus. By immunoblotting and -fluorescence we could
demonstrate the expression of neuritin in cultured human
podocytes and in glomeruli of healthy human kidneys. Previous
studies revealed the involvement of neuritin in tumorigenesis by
promoting changes in cell morphology, anchorage-independent
growth and tumor formation [51] and demonstrated that its
expression could be induced in endothelial cells by hypoxia,
implicating a role of neuritin in vessel pathfinding and network
formation [52]. Recent studies showed that neuritin expression
increased following ischemia and reperfusion in rats [53] and that
it mediates NGF-induced axonal regeneration and is deficient in
experimental diabetic neuropathy [54].
For ROBO1 and -2 mRNA a glomerular overexpression of up
to 100 fold compared to the tubulointerstitium could be observed
(Figure 3). Supporting the mRNA results we found by immuno-
blotting and -fluorescence a clear presence of robo1 in cultured
Figure 3. Evaluation of neuron-associated genes by real-time RT-PCR. Expression of NRN1, ROBO1, ROBO2, and NPDC1 mRNA in an
independent cohort of microdissected samples of allograft donors normalized to the tubulointerstitial expression (n = 10). * p,0.05; ** p,0.01. The
data shown are normalized to the mean of the two reference genes, GAPDH and 18S rRNA.
doi:10.1371/journal.pone.0011545.g003
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human podocytes and in glomeruli of healthy human control
kidneys. Robo1 and -2, members of the roundabout receptor
family, are single-transmembrane receptors that respond to
secreted slit proteins and act as repellents regulating the migration
of neurons and axons, but are also involved in inhibition of
leukocyte chemotaxis, tumor angiogenesis and endothelial cell
migration [55,56,57]. It is known that robo and slit genes are not
only expressed in the brain, but can be found in a range of tissues.
Previous rodent studies could demonstrate that the slit and robo
gene families are expressed in the developing murine kidney and
that disruption of the slit-robo signaling is associated with
congenital anomalies of the kidney and urinary tract [58,59,60].
Furthermore Fan et al. just recently reported that podocyte-
specific deletion of robo2 in mice developed significant albuminuria
which was associated with increased glomerular collagen deposi-
tion, mesangial matrix expansion and podocyte foot-process
effacement [61]. In accordance with these results are our findings
of decreased levels of ROBO2 mRNA in human diabetic
nephropathy and focal segmental glomerulosclerosis. It is known
that axon extension and guidance require a coordinated assembly
of F-actin and microtubules. Different studies showed that the slit-
robo transduction pathway acts via a specific family of GTPase-
activating proteins (GAPs) named slit-robo GAPs (srGAPS). These
srGAPs further transmit the signal to the actin cytoskeleton
controlling Rho GTPases such as CDC42 or rac1 and thus
provide a direct link between slit-robo signaling and actin
cytoskeleton [62]. Studies from Kobayashi et al showed that
alterations of the activity of the rho family small GTPases leads to
changes in actin filament assembly and in foot process formation
[45]. In this context, the finding of robo1 and -2 in podocytes
indicate a possible role in the regulation of the complex
cytoskeletal structure of these cells which is also strengthened by
the presence of srGAPs and downstream targets of the slit-robo
signaling pathways in our REGGED.
In conclusion, we successfully generated a human glomerulus-
enriched gene expression dataset (REGGED) which allowed us to
Figure 4. Western Blot analysis of robo1 (A) and neuritin (B) in
human podocytes. For robo1 (A) and neuritin (nrn1) (B), a band of the
expected size was found in a human podocyte cell line; human brain
lysate served as a positive control. Beta-actin was used as an internal
loading control.
doi:10.1371/journal.pone.0011545.g004
Figure 5. Immunofluorescence of robo1 (A) and neuritin (B) in human podocytes. In undifferentiated, immortalized podocytes (33uC) the
expression of robo1 seemed to be more cytoskeletal, while in differentiated cells (37uC) a more intensive staining as well as a more pronounced
staining at the cell border was found. For neuritin a cytoskeletal staining pattern could be observed in undifferentiated and differentiated cells with in
the latter pronounced staining of stress fibers.
doi:10.1371/journal.pone.0011545.g005
Glomerular Gene Expression
PLoS ONE | www.plosone.org 7 July 2010 | Volume 5 | Issue 7 | e11545
identify novel genes expressed predominantly in the human
glomerulus. Pathways which have not previously been associated
with glomerular biology were identified. A systematic analysis of
this dataset allows the detection of target molecules and biological
processes involved in glomerular biology and renal disease. We
believe that REGGED will fuel ongoing and future research on
glomerular biology and disease.
Materials and Methods
Renal biopsies for mRNA analysis
Human renal biopsy specimens were procured in an international
multicenter study, the European Renal cDNA Bank-Kroener-
Fresenius biopsy bank (ERCB-KFB, see appendix for participating
centers [63]). Renal biopsies were obtained after written consent and
approval of the ethics committee and in the frame of the European
Renal cDNA Bank approved by the specialized subcommittee for
internal medicine of the cantonal ethics committee of Zurich. All
kidney donors had normal renal function, no proteinuria and no
arterial hypertension. Glomeruli and the tubulointerstitial specimen
were microdissected as described previously [63]. The data discussed
in this publication have been deposited in NCBI’s Gene Expression
Omnibus [64] and are accessible through GEO Series accession
number GSE21785 (http://www.ncbi.nlm.nih.gov/geo/query/acc.
cgi?acc=GSE21785) and will also be made available online at
http://www.nephromine.org.
For validation of the microarray data, qRT-PCR on biopsies
from an independent cohort of living donors (LD, n= 10) was
performed. Furthermore, cohorts of patients with diabetic
nephropathy (DN, n= 14), focal segmental glomerulosclerosis
(FSGS; n= 17), membranous nephropathy (MGN; n= 17),
nephrosclerosis (NSC; n= 14) and controls (living donors (LD)
n= 8) were used for gene expression analysis by qRT-PCR
(Supplementary Table S11).
Target preparation
RNA was isolated as described previously [63]. Total RNA was
reverse-transcribed (RT) and linearly amplified according to a
protocol previously reported for tubulointerstitial specimen [65]
and glomeruli [66], respectively. The fragmentation, hybridiza-
tion, staining and imaging were performed according the
Affymetrix Expression Analysis Technical Manual.
Microarray Data Analysis
Normalization. To compare the respective glomerular and
tubulointerstitial gene expression profiles we performed background
adjustment, quantile normalization and probeset summarization
using Robust Multichip Analysis (RMA) using RMAexpress version
0.3 [67] with settings from previous studies [65].
Comparison. The comparison of tubulointerstitial and
glomerular expression relies on the assumption that only a small
subset of genes shows compartment specific expression and as a
corollary almost all show equal expression. However, as
glomerular and tubulointerstitial specimen were hybridized to
the microarrays separately, we had to consider the possibility of
systematic error leading to pairwise different expression values of
the genes. For example, a positive shift of the glomerular data
would make genes with truly similar expression appear to have
higher expression in glomeruli. Therefore an adjustment of the
data prior to any analysis is crucial to avoid the introduction of
false positives and false negatives. Standard normalization
methods are designed to remove rather minor technical
variation evenly distributed across samples. As we have
experienced a more pronounced effect on the two blocks of data
we decided to normalize the sets separately and subsequently
adjust the data as follows using a linear function.
While the underlying causes of this error type can be complex
and hard to discern, a linear function provides a sensible starting
point. In detail, this means to find an additive factor (difference of
base expression) and a multiplicative one (difference in dynamic
range) and apply this function to one of the datasets. By
subsequent subtraction of the tubulointerstitial from the glomer-
ular dataset we expected to find many values close to 0, the ones
with positive result being our candidates for preferential
glomerular expression.
To determine the factors, we calculated the mean of each probeset
across all the samples in each condition, resulting in an aggregate
expression profile for glomeruli and tubulointerstitium. After sorting
Figure 6. Immunofluorescence of robo1 (A) and neuritin (B) in
human control kidneys. Immunofluorescence for robo1 (A) shows a
constitutive expression in glomeruli, while there is no expression in the
tubulointerstitium. Immunostaining for neuritin (B) shows a clear
glomerular expression associated to some positivity in the tubulointer-
stitium. The hatched line displays the glomerular contour (indirect
immunofluorescence, DAPI nuclear counterstain, 200X).
doi:10.1371/journal.pone.0011545.g006
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both by ascending expression level of tubulointerstitium, we
generated a line of best fit, its slope (multiplicative factor) and
intercept (additive factor) for both datasets (glomeruli:
y =0.1641x+2.8035, tubulointerstitium: y=0.1771x+1.5913). To
adjust tubulointerstitium to glomeruli we multiplied each value by
(0.1641/0.1771)=0.9265951 and added (2.803521.5913)= 1.3022.
To minimize effects of sorting, we repeated the same procedure after
sorting by the glomeruli data and used the means of slope and
intercept for the final adjustment function (y= 0.9392425x +
1.17905). Next we subtracted the corrected tubulointerstitial from
glomerular expression values and calculated the standard deviation of
this difference. The selection criterion for preferential glomerular
expression was set as an expression difference exceeding twice this
standard deviation (mean + 2*SD=1.76) resulting in a dataset of 817
glomerular-enriched probesets. After removing unannotated probe-
sets and redundant probesets a list of 677 glomerular-overrepresen-
tated genes remained (Table S1).
Digital Differential Display (DDD)
DDD, a bioinformatic tool available at the National Center for
Biotechnology Information (www.ncbi.nlm.nih.gov/UniGene/in-
fo_ddd.html), analyzes the frequencies of cDNA and expressed
sequence tag (EST) in expression libraries [34]. The DDD tool was
used to compare human cDNA libraries of indicated organs or
cells (i. e. normal adult brain, coronary artery smooth muscle cells,
muscle and heart) with other organ cDNA libraries except testis as
described previously [34].
Analysis of biological processes and pathways
GOs and pathways were identified using a combination DAVID
Bioinformatics database from the NIAID, NIH (Version 2010)
(http://david.abcc.ncifcrf.gov/) [68,69] and the KEGG database
from the University of Kyoto (http://www.genome.jp/kegg/
kegg2.html) [70,71].
To obtain a more structured biological picture the functional
annotation cluster analysis tool of DAVID was applied on
REGGED. This analysis tool measures relationships among the
annotation terms by using Kappa-statistics and is able to organize
and cluster redundant and heterogeneous annotation terms into
functional annotation groups which can provide a better
understanding of the biological meaning for the given dataset
[33].
For all DAVID analyses a p-value (Ease score) of 0.05 and fold
enrichment of at least 1.5 was used as standard cut-off level. As
gene reference background the Affymetrix HT human genome
U133A available in DAVID was used [33,69].
Figure 7. Glomerular mRNA expression of NRN1, ROBO1 and 2 mRNA in human DN, NSC, FSGS and MGN. Levels of mRNA for NRN1 (A),
ROBO1 (B) and ROBO2 (C) were quantified in microdissected glomeruli from controls (n=8), patients with established DN (DN, n=14), NSC (n=14), FSGS
(FSGS, n=17) and from patients with MGN (n=17). ROBO2 was significantly down-regulated in diabetic nephropathy compared to control samples as
indicated by the respective p-value, while ROBO1 and NRN1 showed no regulation. The graphs show expression ratios of each gene normalized to hGAPDH.
doi:10.1371/journal.pone.0011545.g007
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Quantitative real-time RT-PCR
Reverse transcription and qRT-PCR was performed as
reported earlier [63]. Pre-developed TaqMan reagents were used
for human NRN1 (Hs00213192_m1), NPDC1 (Hs00209870_m1),
ROBO1 (Hs00268049_m1) as well as the housekeeper genes
(Applied Biosystems Europe, Rotkreuz, Switzerland). For the
human ROBO2 (NM_002942), the following oligonucleotide
primers (300 nmol/L) and probe (100 nmol/L) were used: sense
primer 59- ATTGAGGCTTTCAGCCAATCA-39, antisense
primer 59- TGATCGCTCTGACCATGAATAAGT-39; fluores-
cence labeled probe (FAM) 59- TGAGCAACAGCTGGCA-
GACCGTG-39. The expression of candidate genes was normal-
ized by two reference genes, 18S rRNA and GAPDH, giving
comparable results. The mRNA expression was analyzed by the
delta delta Ct method for renal compartment analysis or standard
curve quantification for disease-specific expression analysis.
Western Blot
Robo1: Cultured human glomerular epithelial cells [72] were
harvested with lysis buffer A (2% Triton, 150 mM NaCl,
100 mM HEPES, 2 mM EGTA, 2 mM Na3VO4, and Complete
Protease Inhibitor Cocktail [Roche, Mannheim, Germany]).
Extracted proteins were boiled in loading buffer for 5 min,
resolved by 6% SDS-PAGE under reducing conditions, and
transferred to an Immobilon-P membrane (Millipore, Eschborn,
Germany).
Neuritin: Cultured human podocytes [72] were lysed with
buffer B (150 mM NaCl, 1% Nonidet P-40, 0.5% DOC, 0.1%
SDS, 50 mM Tris, pH 8.0, 100 mM DTT, 6M Urea and
Complete Protease Inhibitor Cocktail [Roche, Mannheim,
Germany]. Extracted proteins were heated for 15 min at 37uC,
resolved by 16% Tricine-SDS-PAGE, containing 6M Urea [73]
under reducing conditions, and transferred to an Immobilon-P
membrane (Millipore, Eschborn, Germany).
Equal loading and transfer efficiency were verified by staining
with 2% Ponceau S. Membranes were blocked overnight with
Tris-buffered saline (TBS)/3% fat-free skim milk and then
incubated with either a polyclonal rabbit anti-robo1 (Abcam,
Cambridge, UK) diluted 1:500 overnight at 4uC, or polyclonal
rabbit anti-neuritin (Lifespan Biosciences, Seattle, WA, USA)
diluted 1:500 overnight at 4uC and rinsed with TBS that contained
0.1% Tween 20. For detection, a donkey anti-rabbit IgG ECL
antibody, HRP conjugated (1:10000, 1 hour at room temperature;
GE Healthcare, Chalfont St. Giles, UK) and enhanced chemilu-
minescence substrate (PerkinElmer, Waltham, MA, USA) were
used. Membranes were also probed with anti-beta-actin antibody
(A 5316, 1:5000, Sigma-Aldrich, Germany) as internal loading
control.
Immunofluorescence staining of human podocytes
Cells were fixed with 2% paraformaldehyde and 4% sucrose at
room temperature for 10 min. The cells were then washed once
with PBS, permeabilized with 0.3% Triton X-100 for 10 min and
incubated with blocking solution (2% FCS, 2% BSA, 0.2% fish
gelatin) for 30 min, before further incubation with a polyclonal
rabbit anti-robo1 (Abcam, Cambridge, UK) or a polyclonal
rabbit anti-neuritin antibody (Lifespan Biosciences, Seattle, WA,
USA) for 1 h. For immunofluorescence detection, Alexa Fluor
488 goat anti-rabbit IgG secondary antibody (Invitrogen,
Molecular Probes, Paisley, UK) were used at a dilution of
1:200. For nuclear counterstaining, tissue sections were mounted
with Vectashield with DAPI (Vector Laboratories, Burlinghame,
CA, USA).
Immunofluorescence staining of human control kidneys
Kidney tissue was obtained from the healthy pole of kidneys
removed because of small and localized tumors. For immunoflu-
orescence, the unfixed renal tissue was embedded in OCT
(optimum cutting temperature cryoembedding matrix) (Tissue-
Tek, Electron Microscopy Sciences, Societa` Italiana Chimici,
Roma, Italy), snap-frozen in a mixture of isopentane and dry ice,
and stored at 280uC. Indirect immunofluorescence was per-
formed on 5-mm-thick tissue cryosections fixed in cold acetone
with the primary antibodies rabbit anti-robo1 and rabbit anti-
neuritin (both from Novus Biologicals, DBA Italia, Milan, Italy).
Sections were incubated for 30 min with a fluorescent-labelled
goat anti-rabbit secondary antibody (Alexafluor 488; Invitrogen,
Milan, Italy) and nuclei counterstained by DAPI. Specificity of
antibody labelling was demonstrated by the lack of staining after
substituting proper control immunoglobulins (Rabbit primary
antibody isotype control, Invitrogen) for the primary antibodies.
Slides were mounted with Fluorsave aqueous mounting medium
(Calbiochem, VWR International, Milan, Italy). Images were
acquired by a Zeiss Axioscope 40FL microscope, equipped with
AxioCam MRc5 digital videocamera and immunofluorescence
apparatus (Carl Zeiss SpA, Arese, Mi, Italy), and recorded using
AxioVision software 4.3.
Statistics
Experimental data are given as mean 6 SD. Statistical analysis
was performed using Kruskall-Wallis and Mann-Whitney U tests
(SPSS 17.0, SPSS Inc., Chicago, IL). P-values less than 0.05 were
considered to indicate statistically significant differences.
Supporting Information
Figure S1 DAVID Functional Annotation Cluster Analysis -
genes involved in functional clusters. The terms involved in the
respective functional annotation clusters are described in Table
S5. Genes which are involved in the respective functional
annotation cluster are shown in black.
Found at: doi:10.1371/journal.pone.0011545.s001 (0.06 MB
PDF)
Table S1 Renal glomerulus-enriched gene expression dataset
(REGGED). 677 renal genes were identified to be enriched in the
human glomerulus.
Found at: doi:10.1371/journal.pone.0011545.s002 (0.72 MB
DOC)
Table S2 List of known podocyte-, mesangial- and endothelial-
specific markers as well as validated glomerular gene and protein
expression data.
Found at: doi:10.1371/journal.pone.0011545.s003 (0.35 MB
DOC)
Table S3 Comparison of the 5 different approaches. 1 indicates
the presence of the gene, 0 indicates the absence of the gene in the
respective dataset. Sum: indicates in how many of the databases
the respective gene is found.
Found at: doi:10.1371/journal.pone.0011545.s004 (0.24 MB
XLS)
Table S4 Prominent biological aspects found by DAVID
analysis
Found at: doi:10.1371/journal.pone.0011545.s005 (0.36 MB
DOC)
Table S5 DAVID Functional Annotation Cluster Analysis
Found at: doi:10.1371/journal.pone.0011545.s006 (0.13 MB
DOC)
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Table S6 KEGG pathways
Found at: doi:10.1371/journal.pone.0011545.s007 (0.04 MB
DOC)
Table S7 Neuron/brain-associated gene list
Found at: doi:10.1371/journal.pone.0011545.s008 (0.40 MB
DOC)
Table S8 Neuron/brain-associated genes present in the
REGGED
Found at: doi:10.1371/journal.pone.0011545.s009 (0.07 MB
DOC)
Table S9 Smooth muscle cell associated gene list. Genes marked
in bold font are present in REGGED.
Found at: doi:10.1371/journal.pone.0011545.s010 (0.10 MB
DOC)
Table S10 Muscle- and heart associated gene list. Genes marked
in bold font are present in REGGED.
Found at: doi:10.1371/journal.pone.0011545.s011 (0.16 MB
DOC)
Table S11 Clinical and histological characteristics. Clinical and
histological characteristics of patients and biopsies, respectively,
with established diabetic nephropathy, focal segmental sclerosis
and living donors analyzed by real-time RT-PCR (P) and
oligonucleotide array based gene expression profiling (A) (for
living donor). * = blood pressure before biopsy [mmHg].
Found at: doi:10.1371/journal.pone.0011545.s012 (0.15 MB
DOC)
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